TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC
Recruiting · NCT07246304 · Registry updated 2025-11-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Early phase 1 | 2025-11-24 | NCT07246304 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TCRCure Biopharma Ltd. | 3 |
| The Jinling Hospital | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Jinling Hospital | Nanjing | China | 2 |